L90.0
Lichen sclerosus et atrophicus
Clinical Classification Guidelines
Excludes Type 2
- lichen sclerosus of external female genital organs (N90.4)
- lichen sclerosus of external male genital organs (N48.0)
Medical Intelligence & Overview
Lichen sclerosus et atrophicus is a chronic skin condition that primarily affects the genital and anal areas but can also occur on other parts of the body. It leads to the development of thin, white patches of skin that can cause discomfort and scarring. Although the exact cause of the condition is unknown, it is considered an autoimmune disorder, meaning the body's immune system mistakenly attacks healthy skin tissue. Lichen sclerosus can affect individuals of any age, but it is most common in women, especially after menopause. Recognizing the symptoms early and seeking appropriate management can help reduce discomfort and prevent potential complications.
Causes & Symptoms
Clinical Causes: Autoimmune processes where the immune system attacks skin tissues Genetic predisposition or family history of autoimmune diseases Hormonal factors, particularly estrogen deficiency in postmenopausal women Trauma or skin injury to affected areas Infections or other skin conditions that may trigger immune response Potential environmental factors, such as skin irritants or allergens
Key Symptoms: White, shiny, or porcelain-like patches of skin, often thinner than surrounding tissue Itching or a burning sensation in affected areas Bleeding or soreness, especially after scratching or friction Detachment or scarring of skin in severe cases Pain during sexual intercourse or discomfort in sensitive regions Changes in skin texture and appearance over time, including toughening or scarring In some cases, skin may become numb or lose sensation
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a physical examination by a healthcare provider who will assess the characteristic skin changes. In some cases, a biopsy may be performed—where a small sample of skin is examined under a microscope—to confirm the diagnosis and rule out other skin conditions. Recognition of symptoms and characteristic appearance usually guide the diagnosis, but additional tests can help ascertain the extent of skin involvement or associated issues.
Treatment Protocols: While there is no cure for lichen sclerosus et atrophicus, various treatments aim to relieve symptoms, prevent progression, and reduce the risk of complications. Treatment strategies include: - **Topical corticosteroids**: The mainstay of treatment to reduce inflammation and itching. - **Emollients and moisturizers**: To keep the skin moist and prevent irritation. - **Immunomodulators**: Such as topical calcineurin inhibitors for cases resistant to corticosteroids. - **Lifestyle modifications**: Including gentle skin care routines, avoiding irritants, and wearing loose garments. - **Regular follow-up**: To monitor the condition and modify treatment as needed. - **Surgical options**: In rare cases, surgical procedures may be considered for severe scarring or functional impairment. Managing associated discomfort and monitoring for potential complications, such as scarring or increased risk of skin cancer in affected areas, are essential components of ongoing care.
Clinical Advice & FAQs
Billing Guidance
Is L90.0 a billable ICD-10 code?
Yes, L90.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L90.0?
Clinical documentation must specify the nature of Lichen sclerosus et atrophicus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference